Deal News - ROHDE BAIER advises Nanoris Holding on investment in MoleQlar

Frankfurt am Main, 23 July 2024. 

Transaction boutique ROHDE BAIER advises Nanoris Holding GmbH for investment in MoleQlar GmbH

MoleQlar (pron. Molecular) is a science-based longevity company and a link to innovation in the field of health and longevity research. Since its foundation in 2020, the company has become the market leader for longevity solutions in German-speaking countries.

The ROHDE BAIER The team was led by partner Thorsten Rohde (M&A/PE, Frankfurt). The parties have agreed not to disclose financial details. 

Thorsten Rohde comments: "We are delighted that we were able to support Nanoris Holding with this far-sighted investment in MoleQlar."

ROHDE BAIER Attorneys at Law with locations in Frankfurt am Main and Munich combines the quality and experience of major international law firms with an economic solution-orientation, pragmatism and industry expertise in a powerful boutique law firm. The team from ROHDE BAIER is at your disposal as a sparring partner for corporate transactions and all issues relating to company, commercial and property law.

Share this article on LinkedIn

More from our blog

Set language: